Trial intelligence / Profile preview

Volumekinetics of hyperoncotic albumin in burn patients and healthy volunteers

2016-000996-26Phase 4Completed

Sponsor
Region Östergötland
Start
Apr 2016
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of albumin (human) in burn injury (2 arms), sponsored by Region Östergötland. Primary endpoint: Plasma volume expansion at 4 hours. Started Apr 2016; status: completed.

02

Drugs

albumin (human)
03

Conditions

burn injury

Beyond the preview

Go deeper on 2016-000996-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000996-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call